Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - levetiracetam, quantity: 10 % w/v - oral liquid, solution - excipient ingredients: acesulfame potassium; propyl hydroxybenzoate; purified water; maltitol solution; glycerol; sodium citrate dihydrate; methyl hydroxybenzoate; ammonium glycyrrhizinate; citric acid monohydrate; flavour - levetiracetam-aft oral solution is indicated for:,use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation,,monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy.,add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme),and,add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (ige).,levetiracetam-aft concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.

Australia - English - Department of Health (Therapeutic Goods Administration)

ucb australia pty ltd t/a ucb pharma division of ucb australia - levetiracetam, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: acesulfame potassium; purified water; maltitol solution; methyl hydroxybenzoate; ammonium glycyrrhizinate; citric acid monohydrate; propyl hydroxybenzoate; sodium citrate dihydrate; glycerol; flavour - keppra (film coated tablets and oral solution) is indicated for - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation, - monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. - add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme), and - add on therapy in the treatment of primary generalised tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige). keppra concentrate solution for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible.

Canada - English - Health Canada

teva canada limited - levetiracetam - tablet - 250mg - levetiracetam 250mg - miscellaneous anticonvulsants

Canada - English - Health Canada

teva canada limited - levetiracetam - tablet - 500mg - levetiracetam 500mg - miscellaneous anticonvulsants

Canada - English - Health Canada

teva canada limited - levetiracetam - tablet - 750mg - levetiracetam 750mg - miscellaneous anticonvulsants

Canada - English - Health Canada

apotex inc - levetiracetam - tablet - 250mg - levetiracetam 250mg - miscellaneous anticonvulsants

Canada - English - Health Canada

apotex inc - levetiracetam - tablet - 500mg - levetiracetam 500mg - miscellaneous anticonvulsants

Canada - English - Health Canada

apotex inc - levetiracetam - tablet - 750mg - levetiracetam 750mg - miscellaneous anticonvulsants

Canada - English - Health Canada

auro pharma inc - levetiracetam - tablet - 250mg - levetiracetam 250mg - miscellaneous anticonvulsants

Canada - English - Health Canada

auro pharma inc - levetiracetam - tablet - 500mg - levetiracetam 500mg - miscellaneous anticonvulsants